2022
DOI: 10.3390/pharmaceutics15010008
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Lipid Composition of Cationic Liposomes 2X3-DOPE on mRNA Delivery into Eukaryotic Cells

Abstract: The design of cationic liposomes for efficient mRNA delivery can significantly improve mRNA-based therapies. Lipoplexes based on polycationic lipid 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetraazahexacosane tetrahydrochloride (2X3) and helper lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were formulated in different molar ratios (1:1, 1:2, 1:3) to efficiently deliver model mRNAs to BHK-21 and A549. The objective of this study was to examine the effect of 2X3-DOPE composition as wel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 33 publications
(64 reference statements)
0
10
0
Order By: Relevance
“…DOPE, a zwitterionic lipid, is added for its fusiogenic property, which promote endosomal escape of siRNA into the intracellular compartment [37]. Our previous findings demonstrate that an increase in the proportion of DOPE in liposome formulations, based on 2X3, enhances the efficiency of mRNA delivery to eukaryotic cells [38]. The addition of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-PEG 2000 ) plays a significant role in achieving efficient nuclease protection of siRNA and prolonged drug release of the PEGylated lipoplexes [39].…”
Section: Resultsmentioning
confidence: 99%
“…DOPE, a zwitterionic lipid, is added for its fusiogenic property, which promote endosomal escape of siRNA into the intracellular compartment [37]. Our previous findings demonstrate that an increase in the proportion of DOPE in liposome formulations, based on 2X3, enhances the efficiency of mRNA delivery to eukaryotic cells [38]. The addition of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-PEG 2000 ) plays a significant role in achieving efficient nuclease protection of siRNA and prolonged drug release of the PEGylated lipoplexes [39].…”
Section: Resultsmentioning
confidence: 99%
“…RNA transfections were performed using 2X3-DOPE (1:3) Reagent [9]. RNA complexes were formed in serum-free medium by mixing 0.73 µl of 2X3-DOPE (1:3) reagent and 100 ng synthetic mRNA per well of 96-well plate or 300 ng per well of 12-well plate.…”
Section: Cell Transfectionmentioning
confidence: 99%
“…1−3 Among them, cationic liposomes with the ability of cationic lipids to bind RNAs are frequently used for nucleic acid delivery. 4 However, cationic liposomes also cause cytotoxicity by electrostatic binding to the cell membrane, which seriously compromises the results of clinical trials. To solve this problem, researchers conjugated PEG chains to lipids, obtained poly(ethylene glycol) (PEG)-lipid derivatives, and prepared PEGylated cationic liposomes with PEG chains.…”
Section: Introductionmentioning
confidence: 99%
“…Lipid nanoparticles are promising nanomedicine delivery vehicles that have recently gained much attention because of their remarkable success as a delivery platform for COVID-19 mRNA vaccines. Among them, cationic liposomes with the ability of cationic lipids to bind RNAs are frequently used for nucleic acid delivery . However, cationic liposomes also cause cytotoxicity by electrostatic binding to the cell membrane, which seriously compromises the results of clinical trials.…”
Section: Introductionmentioning
confidence: 99%